by Elena Iemma | May 16, 2023 | News
EpiVax is celebrating 25 years of innovative immunoinformatics tool development. The company’s mission is to improve the safety and efficacy of vaccines and protein therapeutics, while working to improve human health everywhere. 1998 EpiVax...
by Elena Iemma | Jun 10, 2022 | News
PROVIDENCE, RI, June 10, 2022 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) announces that it has developed VennVax, a smallpox vaccine candidate that is predicted to be highly effective against monkeypox. The development of this vaccine was funded by the National...
by Adam | Mar 4, 2020 | News
PROVIDENCE, R.I., Mar. 4, 2020 – EpiVax Inc., a Rhode Island company, announces a collaboration to develop a novel coronavirus SARS-CoV-2 (COVID-19) vaccine with University of Georgia (UGA, Athens GA) vaccine expert Ted Ross (Director, Center for Vaccines and...
by Annie De Groot | Feb 28, 2020 | Events
The 2020 meeting for the National Foundation for Infectious Diseases is taking place at the The Omni Shoreham Hotel in Washington DC, from March 23-25. During the meeting, EpiVax will be represented by Dr. Lenny Moise, director of Vaccines, Dr. Lauren Meyers, of the...
